Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000819567 | SCV000960234 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2018-12-31 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg487 amino acid residue in TGFBR1. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 16791849, 18455604, 22113417, 23884466, 15731757, 16928994, 22414221, 25110237), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been observed in an individual affected with Loeys-Dietz syndrome (PMID: 23884466). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glycine at codon 487 of the TGFBR1 protein (p.Arg487Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine. |